Search Results - "GROP, A"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS by ZIVADINOV, R, RUDICK, R. A, DE MASI, R, NASUELLI, D, UKMAR, M, POZZI-MUCELLI, R. S, GROP, A, CAZZATO, G, ZORZON, M

    Published in Neurology (09-10-2001)
    “…IV methylprednisolone (IVMP) has been used to treat relapses in patients with relapsing-remitting (RR) MS, but its effect on disease progression is not known…”
    Get full text
    Journal Article
  2. 2

    Epstein–Barr virus is associated with grey matter atrophy in multiple sclerosis by Zivadinov, R, Zorzon, M, Weinstock-Guttman, B, Serafin, M, Bosco, A, Bratina, A, Maggiore, C, Grop, A, Tommasi, M A, Srinivasaraghavan, B, Ramanathan, M

    “…Objective:The aim of the study was to determine whether the presence of anti-Epstein–Barr virus (EBV) antibodies is associated with MRI measures of brain…”
    Get full text
    Journal Article
  3. 3

    A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis by Zivadinov, R, Sepcic, J, Nasuelli, D, De Masi, R, Bragadin, L Monti, Tommasi, M A, Zambito-Marsala, S, Moretti, R, Bratina, A, Ukmar, M, Pozzi-Mucelli, R S, Grop, A, Cazzato, G, Zorzon, M

    “…OBJECTIVE (a) To establish whether the cognitive decline of the early phase of relapsing-remitting multiple sclerosis depends on the progression of the burden…”
    Get full text
    Journal Article
  4. 4

    Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy by Zivadinov, R, Locatelli, L, Cookfair, D, Srinivasaraghavan, B, Bertolotto, A, Ukmar, M, Bratina, A, Maggiore, C, Bosco, A, Grop, A, Catalan, M, Zorzon, M

    Published in Multiple sclerosis (01-05-2007)
    “…Brain atrophy, as assessed by magnetic resonance imaging (MRI), has been correlated with disability in patients with multiple sclerosis (MS). Recent evidence…”
    Get full text
    Journal Article
  5. 5

    MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis by ZIVADINOV, R, DE MASI, R, NASUELLI, D, BRAGADIN, L. Monti, UKMAR, M, POZZI-MUCELLI, R. S, GROP, A, CAZZATO, G, ZORZON, M

    Published in Neuroradiology (01-04-2001)
    “…Correlation studies between various conventional and non-conventional MRI parameters and cognitive impairment in the early stages of multiple sclerosis (MS)…”
    Get full text
    Journal Article
  6. 6

    Depressive symptoms and MRI changes in multiple sclerosis by Zorzon, M., Zivadinov, R., Nasuelli, D., Ukmar, M., Bratina, A., Tommasi, M. A., Mucelli, R. P., Brnabic-Razmilic, O., Grop, A., Bonfigli, L., Cazzato, G.

    Published in European journal of neurology (01-09-2002)
    “…To determine whether changes in specific regions of the brain can contribute to the development of depression in patients with multiple sclerosis (MS). We…”
    Get full text
    Journal Article
  7. 7

    I nterferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy by Zivadinov, R., Locatelli, L., Cookfair, D., Srinivasaraghavan, B., Bertolotto, A., Ukmar, M., Bratina, A., Maggiore, C., Bosco, A., Grop, A., Catalan, M., Zorzon, M.

    Published in Multiple sclerosis (01-05-2007)
    “…Background Brain atrophy, as assessed by magnetic resonance imaging (MRI), has been correlated with disability in patients with multiple sclerosis (MS). Recent…”
    Get full text
    Journal Article
  8. 8

    Single-breath method for assessing the viscoelastic properties of the respiratory system by Antonaglia, V, Grop, A, Demanins, P, Beltrame, F, Lucangelo, U, Peratoner, A, De Simoni, L, Gullo, A, Milic-Emili, J

    Published in The European respiratory journal (01-11-1998)
    “…In order to explain the time dependency of resistance and elastance of the respiratory system, a linear viscoelastic model (Maxwell body) has been proposed. In…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Frontal parenchymal atrophy measures in multiple sclerosis by Locatelli, Laura, Zivadinov, Robert, Grop, Attilio, Zorzon, Marino

    Published in Multiple sclerosis (01-10-2004)
    “…The aim of this study was to establish whether, in a cross-sectional study, the normalized measures of whole and regional brain atrophy correlate better with…”
    Get full text
    Journal Article
  11. 11
  12. 12

    MMP-9 microsatellite polymorphism and multiple sclerosis by Fiotti, Nicola, Zivadinov, Robert, Altamura, Nicola, Nasuelli, Davide, Bratina, Alessio, Tommasi, Maria Antonietta, Bosco, Antonio, Locatelli, Laura, Grop, Attilio, Cazzato, Giuseppe, Guarnieri, Gianfranco, Giansante, Carlo, Zorzon, Marino

    Published in Journal of neuroimmunology (01-07-2004)
    “…A polymorphism (PM) in the microsatellite of the promoter region of matrix metalloproteinase 9 (MMP-9), modulating its expression, could play a role in…”
    Get full text
    Journal Article
  13. 13

    HLA B7/A2, Epstein-Barr Virus antibodies and magnetic resonance imaging in multiple sclerosis: a case for gene-environment interactions by Zivadinov, R, Weinstock-Guttman, B, Zorzon, M, Uxa, L, Serafin, M, Bosco, A, Bratina, A, Maggiore, C, Grop, A, Tommasi, MA, Srinivasaraghavan, B, Ramanathan, M

    Published in Multiple sclerosis (01-09-2008)
    “…Background: The underlying gene-gene interactions and gene-environment interactions can potentially cause the heterogeneity in brain inflammation,…”
    Get full text
    Journal Article
  14. 14

    Epstein-Barr virus is associated with gray matter atrophy and lesion injury in multiple sclerosis by Zivadinov, R, Zorzon, M, Weinstock-Guttman, B, Serafin, M, Bosco, A, Bratina, A, Maggiore, C, Grop, A, Tommasi, MA, Srinivasaraghavan, B, Ramanathan, M

    Published in Multiple sclerosis (01-09-2008)
    “…Background: Because Epstein Barr virus (EBV) specifically affects immune cells and is capable of causing the dysimmunity that is a hallmark of multiple…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    β2-microglobulin serum level is not a marker of disease activity in multiple sclerosis by Bagnato, F., Zivadinov, R., Cecchinelli, D., Tancredi, A., Grop, A., Pierallini, A., De Lena, C., Prencipe, M., Reale, G., Zorzon, M., Millefiorini, E.

    Published in European journal of neurology (01-07-2004)
    “…Beta2‐microglobulin (β2‐MG) is a pharmacodynamic marker of interferon‐β activity in multiple sclerosis (MS). Its role in the natural course of the disease is…”
    Get full text
    Journal Article
  19. 19

    Normalized regional brain atrophy measurements in multiple sclerosis by ZIVADINOV, Robert, LOCATELLI, Laura, STIVAL, Barbara, BRATINA, Alessio, GROP, Attilio, NASUELLI, Davide, BRNABIC-RAZMILIC, Ozana, ZORZON, Marino

    Published in Neuroradiology (01-11-2003)
    “…There is still a controversy regarding the best regional brain atrophy measurements in multiple sclerosis (MS) studies. The aim of this study was to establish…”
    Get full text
    Journal Article
  20. 20

    beta2-microglobulin serum level is not a marker of disease activity in multiple sclerosis by Bagnato, F, Zivadinov, R, Cecchinelli, D, Tancredi, A, Grop, A, Pierallini, A, De Lena, C, Prencipe, M, Reale, G, Zorzon, M, Millefiorini, E

    Published in European journal of neurology (01-07-2004)
    “…Beta2-microglobulin (beta2-MG) is a pharmacodynamic marker of interferon-beta activity in multiple sclerosis (MS). Its role in the natural course of the…”
    Get full text
    Journal Article